Guidelines on Donation of Non-Approved Drugs

02.12.2022

On 28 September 2022, the Turkish Medicines and Medical Devices Agency (Agency) published guidelines (Turkish language) on donations from abroad of human medicinal products that are not approved in Turkey on its official website.

The guidelines have been prepared to determine the procedures and principles regarding donations from foreign companies within the scope of the Regulation on Licensing of Human Medicinal Products. The most significant provisions of the guidelines are as follows:

  • In general, donations shall be made in accordance with the World Health Organization's medicine donation guidelines.
  • The donations to be made are evaluated by the Directorate Generals of the Ministry of Health as per the list of medicines needed that is determined and published by the Ministry of Health.
  • In cases where there is no compassionate use programme in the world for a particular medicine, an exceptional application can be made to the Agency for donation on a patient basis.
  • The donation process is initiated by the application of the pharmaceutical company that is willing to donate medicine.
  • If deemed necessary, the Licensing Department of the Agency may be consulted on the quality, safety, and efficacy of the products.

The guidelines also provide the main rules regarding customs clearance for donations and storage, distribution, and delivery of medicines.

The guidelines entered into force as of their date of publication.


First published by Practical Law Life Sciences Monthly Newsletter in 02.12.2022.


Tagged with: Life Sciences & Healthcare, Pharmaceuticals, Human Medicinal Products, Licensing, TITCK, TMMDATurkish Medicines and Medical Devices Agency, Gün + Partners, Dicle Doğan, Beste Turan

This website is available “as is.” Turkish Law Blog is not responsible for any actions (or lack thereof) taken as a result of relying on or in any way using information contained in this website, and in no event shall they be liable for any loss or damages.
Ready to stay ahead of the curve?
Share your interest anonymously and let us guide you through the informative articles on the hottest legal topics.
|
Successful Your message has been sent